Hattersley Gary 4
4 · Nuvation Bio Inc. · Filed Nov 24, 2025
Insider Transaction Report
Form 4
Hattersley Gary
CHIEF SCIENTIFIC OFFICER
Transactions
- Sale
Class A Common Stock
2025-11-20$7.23/sh−69,051$499,032→ 0 total - Sale
Class A Common Stock
2025-11-20$7.23/sh−300,000$2,168,100→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-11-20−300,000→ 200,000 totalExercise: $1.94Exp: 2033-02-27→ Class A Common Stock (300,000 underlying) - Exercise/Conversion
Class A Common Stock
2025-11-20$1.74/sh+69,051$120,149→ 69,051 total - Exercise/Conversion
Class A Common Stock
2025-11-20$1.94/sh+300,000$582,000→ 300,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-11-20−69,051→ 229,884 totalExercise: $1.74Exp: 2030-01-21→ Class A Common Stock (69,051 underlying)
Footnotes (3)
- [F1]Price reported is a weighted-average sales price. The shares were sold at prices ranging from $7.15 to $7.43. The Reporting Person will provide, upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F2]Options vested as to 25% on July 1, 2020 and in equal monthly installments thereafter over the following three years.
- [F3]Options vested as to 25% on the one year anniversary of 2/28/2023, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.